Spreadsheet: f855bd01-9168-4404-8cad-d805ac5790e8
Sheet: Sheet1

Test Referenced | Entry Type | Mayo ID | Description | Reporting Description | Method | Collection Container | Temperature | Stability | [NAME] | Unit of Measure | [NAME] | Minimum Volume | Reject Due To | Reference Values | Days/Times Performed | Analytic Time | Maximum Lab Time | CPT Units | CPT Code | LOINC® Code | LOINC® Attributes | Always Performed | Orderable Separately | Performing Location
FHFIB | Test | FHFIB | Hepatitis C Virus (HCV) FibroSURE | HCV FibroSURE | Immunologic Colorimetric Kinetic - colorimetric Nephelometry | Plastic vial: PlV |  |  | 3 | mL | Draw blood in a plain red-top tube(s) or serum gel tube(s). Separate serum from cells within 1 hour and send 2 tubes of serum,  2.5 mL in first tube and 0.5 mL in second tube frozen in plastic screw-capped tubes. Ship frozen. | 3 mL | Specimens other than	Serum Anticoagulants other than	NA Hemolysis	Mild OK; Gross reject Thawing	NA Lipemia	Mild OK; Gross reject Icteric	NA | TESTS			REFERENCE INTERVAL HCV FibroSURE Results: [NAME]				0.00 - 0.21 [NAME]Necroinflammat Activity Score		0.00 - 0.17 Necroinflammat Activity Grade   Analysis: [NAME], Qn		110 - 276 	mg/dL [NAME]				  34 - 200 	mg/dL Apolipoprotein A-1	      Females:	110 - 205	mg/dL                                           Males:        110 - 180          mg/dL Bilirubin, Total                                                      Newborns, term and near term:                                                         24 hours old:  0.0 -  8.0 mg/dL                                                         48 hours old:  0.0 - 12.2 mg/dL                                                         72 hours old:  0.0 - 15.6 mg/dL                                                         96 hours to 1 month old:  0.0 - 1.2 mg/dL                                                       Children 1 month and older and                                                       Adults:  0.0 - 1.2 mg/dL   GGT		                      Females:             0 - 60	 IU/L                                               Males:                 0 - 65   IU/L ALT (SGPT)                            Females:              0 - 40	 IU/L                                               Males:                 0 - 55   IU/L   Interpretations:  Quantitative results of 6 biochemical tests are analyzed using a  computational algorithm to provide a quantitative surrogate marker (0.0-1.0)  for liver fibrosis (METAVIR F0-F4) and for  necroinflammatory activity (METAVIR A0-A3). [NAME]: 	<0.21 = Stage F0 - No fibrosis 	0.21 - 0.27 = Stage F0 - F1 	0.27 - 0.31 = Stage F1 - Portal fibrosis 	0.31 - 0.48 = Stage F1 - F2 	0.48 - 0.58 = Stage F2 - Bridging fibrosis with few septa 	0.58 - 0.72 = Stage F3 - Bridging fibrosis with many septa 	0.72 - 0.74 = Stage F3 - F4 	          >0.74 = Stage F4 - Cirrhosis Macroinflamm Activity Scoring: 	          <0.17 = [NAME] 	0.17 - 0.29 = [NAME] 	0.29 - 0.36 = [NAME] activity 	0.36 - 0.52 = [NAME] 	0.52 - 0.60 = [NAME] activity 	0.60 - 0.62 = [NAME] 	          >0.62 = [NAME] activity Limitations:  The negative predictive value of a Fibrotest score <0.31 (absence  of clinically significant fibrosis) was 85% when compared to liver  biopsy in 1,270 HCV infected patients with a 38% prevalence of  significant liver fibrosis (F2, 3 or 4). The positive predictive value of  a Fibrotest score >0.48 (F2, 3, 4) was 61% in that same patient  cohort.  HCV FibroSURE is not recommended in patients with   Gilbert Disease, acute hemolysis (e.g. HCV ribavirin therapy  mediated hemolysis),  acute hepatitis of the liver, extra-hepatic   cholestasis, transplant  patients, and/or renal insufficiency patients.  Any of these clinical situations may lead to inaccurate quantitative  predictions of fibrosis and necroinflammatory activity in the liver. Comment:  The performance characteristics of this test have been   determined by LabCorp. This test has not been cleared or   approved by the U.S. Food and Drug Administration (FDA).   The FDA has determined that such clearance or approval is not   currently required. LabCorp is regulated under the Clinical   Laboratory Improvement Amendments of 1988 (CLIA)  and is  certified to perform high complexity testing.   Results and Interpretation Provided By: Lab-Corp RTP 1912 [NAME]Research Triangle Park, NC 27709   Test Performed By:	Lab-Corp Burlington 			1447 York Court 			Burlington, NC 27215-2230 | Varies, Monday through Friday | 10 - 14 days | 16 - 20 days |  | Profile |  |  |  |  | LabCorp Burlington
FHFIB | [NAME] | SERUM | Serum |  |  |  | Frozen
FHFIB | Result | Z0981 | HCV FibroSURE Results: | HCV FibroSURE Results: | Alphanumeric
FHFIB | Result | Z0971 | [NAME] | [NAME] | Numeric |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 48795-9
FHFIB | Result | [NAME] | [NAME] | [NAME] | Alphanumeric |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 48794-2
FHFIB | Result | Z0973 | Necroinflammat Activity Score | Necroinflammat Activity Score | Numeric |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 48792-6
FHFIB | Result | Z0974 | Necroinflammat Activity Grade | Necroinflammat Activity Grade | Alphanumeric |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 48793-4
FHFIB | Result | Z0982 | Analysis: | Analysis: | Alphanumeric
FHFIB | Result | Z0975 | [NAME], Qn | [NAME], Qn | Numeric |  |  |  |  | mg/dL |  |  |  |  |  |  |  |  |  | 1835-8
FHFIB | Result | Z0976 | Haptoglobin | Haptoglobin | Numeric |  |  |  |  | mg/dL |  |  |  |  |  |  |  |  |  | 4542-7
FHFIB | Result | Z0977 | [NAME] | [NAME] | Numeric |  |  |  |  | mg/dL |  |  |  |  |  |  |  |  |  | 1869-7
FHFIB | Result | Z0978 | Bilirubin, Total | Bilirubin, Total | Alphanumeric |  |  |  |  | mg/dL |  |  |  |  |  |  |  |  |  | 1975-2
FHFIB | Result | Z0979 | GGT | GGT | Numeric |  |  |  |  | IU/L |  |  |  |  |  |  |  |  |  | 2324-2
FHFIB | Result | Z0980 | ALT (SGPT) | ALT (SGPT) | Numeric |  |  |  |  | IU/L |  |  |  |  |  |  |  |  |  | 1743-4
FHFIB | Billing Component | FHFIB |  | [NAME], total |  |  |  |  |  |  |  |  |  |  |  |  |  | 1 | 82247
FHFIB | Billing Component | FHFIB |  | Alanine amino (ALT)(SGOT) |  |  |  |  |  |  |  |  |  |  |  |  |  | 1 | 84460
FHFIB | Billing Component | FHFIB |  | Glutamyltransferase,gamma |  |  |  |  |  |  |  |  |  |  |  |  |  | 1 | 82977
FHFIB | Billing Component | FHFIB |  | Apolipoprotein, each |  |  |  |  |  |  |  |  |  |  |  |  |  | 1 | 82172
FHFIB | Billing Component | FHFIB |  | Haptoglobin, quantitative |  |  |  |  |  |  |  |  |  |  |  |  |  | 1 | 83010
FHFIB | Billing Component | FHFIB |  | Nephelometry, each analyt |  |  |  |  |  |  |  |  |  |  |  |  |  | 1 | 83883